Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Selectis Health (GBCS) EBIT Margin (2017 - 2025)

Selectis Health's EBIT Margin history spans 14 years, with the latest figure at 4.09% for Q4 2025.

  • Quarterly results put EBIT Margin at 4.09% for Q4 2025, down 2451.0% from a year ago — trailing twelve months through Dec 2025 was 3.78% (down 249.0% YoY), and the annual figure for FY2025 was 3.78%, down 249.0%.
  • EBIT Margin for Q4 2025 was 4.09% at Selectis Health, down from 2.74% in the prior quarter.
  • In the past five years, EBIT Margin ranged from a high of 20.42% in Q4 2024 to a low of 32.53% in Q4 2023.
  • The 5-year median for EBIT Margin is 4.81% (2021), against an average of 6.24%.
  • The sharpest move saw EBIT Margin plummeted -3216bps in 2021, then skyrocketed 5294bps in 2024.
  • Year by year, EBIT Margin stood at 11.4% in 2021, then dropped by -16bps to 13.27% in 2022, then tumbled by -145bps to 32.53% in 2023, then soared by 163bps to 20.42% in 2024, then tumbled by -120bps to 4.09% in 2025.
  • According to Business Quant data, EBIT Margin over the past three periods came in at 4.09%, 2.74%, and 4.31% for Q4 2025, Q3 2025, and Q2 2025 respectively.